AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1972375 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory parameters including nitrogen balance, acute phase proteins, and liver function tests
Number of subjects: 32
Study 1972375 — intervention group
Group type: EXPERIMENTAL
Intervention: Transient rise of bilirubin
Number of subjects: 32
Study 1972375 — intervention group
Group type: EXPERIMENTAL
Intervention: Rise in acute phase proteins
Number of subjects: 32
Study 6992938 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulphadiazine (T-S)
Number of subjects: 75
Study 6992938 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 31971915 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational workshop
Number of subjects: 64
Study 31971915 — intervention group
Group type: COMPARATOR
Intervention: Educational package
Number of subjects: 64
Study 31050952 — intervention group
Group type: EXPERIMENTAL
Intervention: PBM‐T alone (n = 17), low‐intensity laser (LIL) irradiation (wavelength 660 nm, continuous mode, spot energy 4 J, energy density 142 J/cm2, irradiation time 40 s per spot), once weekly for 4 weeks
Number of subjects: 31
Study 31050952 — intervention group
Group type: EXPERIMENTAL
Intervention: PBM‐T+PDT (n = 14), combination of PBM‐T and PDT with curcumin as photosensitizer, curcumin solution rinse for 5 min, blue light‐emitting diode irradiation for 5 min, LIL applied as in PBM‐T group
Number of subjects: 31
Study 27516235 — intervention group
Group type: EXPERIMENTAL
Intervention: Strict BP control (mean arterial pressure ≤92 mmHg)
Number of subjects: 1067
Study 27516235 — intervention group
Group type: COMPARATOR
Intervention: Usual BP control (mean arterial pressure 102-107 mmHg)
Number of subjects: 1067
Study 27480383 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve growth factor (NGF) injection
Number of subjects: 26
Study 27480383 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline injection (control)
Number of subjects: 26
Study 27480383 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups during saline-induced pain
Number of subjects: 26
Study 24370194 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention (higher fibre intake)
Number of subjects: 1062
Study 24370194 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 1062
Study 24370194 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrushing frequency
Number of subjects: 1062
Study 24370194 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1062
Study 23335901 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram (250 mg/day, N=32)
Number of subjects: 67
Study 23335901 — intervention group
Group type: COMPARATOR
Intervention: Placebo (N=35)
Number of subjects: 67
Study 20027357 — intervention group
Group type: EXPERIMENTAL
Intervention: Afala in complex treatment
Number of subjects: 0
Study 17536986 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 28
Study 17536986 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 28
Study 15117299 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct observation of treatment by community health workers (CHWs)
Number of subjects: 0
Study 15117299 — intervention group
Group type: COMPARATOR
Intervention: Direct observation of treatment by family members
Number of subjects: 0
Study 15117299 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based DOTS implementation
Number of subjects: 0
Study 11805568 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonic transit study (first and second tests)
Number of subjects: 51
Study 11805568 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonic transit study for patients with colonic inertia
Number of subjects: 51
Study 11805568 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonic transit study for patients with paradoxical puborectalis contraction
Number of subjects: 51
Study 11805568 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonic transit study for patients with chronic idiopathic constipation
Number of subjects: 51
Study 11805568 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat transit study confirming inertia before colectomy
Number of subjects: 51
Study 9669221 — intervention group
Group type: EXPERIMENTAL
Intervention: Phlebography
Number of subjects: 24
Study 9669221 — intervention group
Group type: EXPERIMENTAL
Intervention: Duplex ultrasonography
Number of subjects: 24
Study 8149522 — intervention group
Group type: EXPERIMENTAL
Intervention: Hirulog (direct thrombin inhibitor)
Number of subjects: 45
Study 8149522 — intervention group
Group type: COMPARATOR
Intervention: Heparin (control)
Number of subjects: 45
Study 2970776 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tissue plasminogen activator (t‐PA) 150 mg over 8 hours
Number of subjects: 40
Study 2970776 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 2970776 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tissue plasminogen activator (t‐PA)
Number of subjects: 40
Study 29659751 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV vaccine
Number of subjects: 575
Study 29659751 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 575
Study 28215615 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate therapy for 5 years (240 weeks)
Number of subjects: 471
Study 28215615 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline steatosis score of 5% or greater (grade 1 or more)
Number of subjects: 471
Study 28215615 — intervention group
Group type: EXPERIMENTAL
Intervention: Steatosis score at year 5
Number of subjects: 471
Study 28215615 — intervention group
Group type: EXPERIMENTAL
Intervention: HBeAg seropositivity at baseline
Number of subjects: 471
Study 28215615 — intervention group
Group type: EXPERIMENTAL
Intervention: Age 40 years or older
Number of subjects: 471
Study 28215615 — intervention group
Group type: EXPERIMENTAL
Intervention: HBeAg-positive patients with steatosis at baseline
Number of subjects: 471
Study 26305876 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 23926586 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular dermal matrix allografts (ADM group)
Number of subjects: 36
Study 23926586 — intervention group
Group type: COMPARATOR
Intervention: Free gingival grafts (FGG group)
Number of subjects: 36
Study 21068351 — intervention group
Group type: EXPERIMENTAL
Intervention: High-cocoa flavanol (HCF) group (494 mg cocoa flavanols/d)
Number of subjects: 22
Study 21068351 — intervention group
Group type: COMPARATOR
Intervention: Low-cocoa flavanol (LCF) group (23 mg cocoa flavanols/d)
Number of subjects: 22
Study 18948128 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein isolate (WPI) with no GMP
Number of subjects: 50
Study 18948128 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein isolate (WPI) with naturally present 21% GMP
Number of subjects: 50
Study 18948128 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein isolate (WPI) with naturally present 21% GMP plus added GMP
Number of subjects: 50
Study 18948128 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin carbohydrate (control)
Number of subjects: 50
Study 17259090 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus 573L/1‐3 strains
Number of subjects: 46
Study 17259090 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus 573L/1 strain
Number of subjects: 46
Study 17259090 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus strains
Number of subjects: 46
Study 14737725 — intervention group
Group type: EXPERIMENTAL
Intervention: TRAK Assay
Number of subjects: 467
Study 14737725 — intervention group
Group type: EXPERIMENTAL
Intervention: TRAK Dyno human
Number of subjects: 467
Study 10873356 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmentin 1.2 g (intravenous antibiotic prophylaxis)
Number of subjects: 334
Study 10873356 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 334
Study 9093048 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 20
Study 9093048 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 20
Study 9093048 — intervention group
Group type: EXPERIMENTAL
Intervention: Tilt up guided treatment
Number of subjects: 20
Study 1487340 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity training (LO; n = 8)
Number of subjects: 24
Study 1487340 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity training (HI; n = 11)
Number of subjects: 24
Study 1487340 — intervention group
Group type: COMPARATOR
Intervention: Control (CON; n = 5)
Number of subjects: 24
Study 1487340 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 24
Study 3942545 — intervention group
Group type: EXPERIMENTAL
Intervention: Random Dot E (RDE) stereogram
Number of subjects: 483
Study 3942545 — intervention group
Group type: COMPARATOR
Intervention: Modified Clinical Technique (MCT)
Number of subjects: 483
Study 29145076 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative Exercise (IE)
Number of subjects: 47
Study 29145076 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control (WL)
Number of subjects: 47
Study 26321469 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10
Number of subjects: 0
Study 26321469 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Antioxidant Therapy (CAT)
Number of subjects: 0
Study 26321469 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25168637 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity C-reactive protein (hsCRP)
Number of subjects: 281
Study 25168637 — intervention group
Group type: EXPERIMENTAL
Intervention: Matrix metalloproteinase (MMP)-mediated breakdown of CRP (CRPM)
Number of subjects: 281
Study 25168637 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-pain thresholds (PPT)
Number of subjects: 281
Study 25168637 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporal summation of pain
Number of subjects: 281
Study 25168637 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioning pain modulation (CPM)
Number of subjects: 281
Study 22664945 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurotropin
Number of subjects: 80
Study 22664945 — intervention group
Group type: COMPARATOR
Intervention: Control (no neurotropin)
Number of subjects: 80
Study 21029014 — intervention group
Group type: EXPERIMENTAL
Intervention: Masked Hypertension (MH)
Number of subjects: 1019
Study 21029014 — intervention group
Group type: COMPARATOR
Intervention: White-Coat Hypertension (WCH)
Number of subjects: 1019
Study 18410212 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Foundations intervention (8 classes before and after birth)
Number of subjects: 169
Study 18410212 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 169
Study 16078954 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensive intervention group (EIG) - individualized interventions comprising exercise and strategies for maximizing vision and sensation
Number of subjects: 620
Study 16078954 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensive exercise intervention group (part of EIG)
Number of subjects: 620
Study 16078954 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensive visual intervention group (part of EIG)
Number of subjects: 620
Study 16078954 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal intervention group (MIG) - received brief advice
Number of subjects: 620
Study 16078954 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - received no intervention
Number of subjects: 620
Study 12613401 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactovegetarian diet with 10 en% ghee for 8 weeks
Number of subjects: 24
Study 12613401 — intervention group
Group type: COMPARATOR
Intervention: Mustard oil diet (control)
Number of subjects: 24
Study 10619581 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg ramipril daily for 6 weeks
Number of subjects: 28
Study 10619581 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 8533913 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane at 0.5 MAC (3.5%)
Number of subjects: 9
Study 8533913 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane at 0.8 MAC (5.6%)
Number of subjects: 9
Study 8533913 — intervention group
Group type: COMPARATOR
Intervention: Control (no anesthesia)
Number of subjects: 9
Study 2035795 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam and droperidol
Number of subjects: 0
Study 2035795 — intervention group
Group type: COMPARATOR
Intervention: Papaveretum and hyoscine
Number of subjects: 0
Study 7243896 — intervention group
Group type: EXPERIMENTAL
Intervention: Applied kinesiology technique
Number of subjects: 20
Study 7243896 — intervention group
Group type: COMPARATOR
Intervention: Placebo technique
Number of subjects: 20
Study 31125701 — intervention group
Group type: EXPERIMENTAL
Intervention: High‐intensity interval training (HIIT - 10 × 1:1 min 100% VO2max; n = 13)
Number of subjects: 32
Study 31125701 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate‐intensity continuous training (MICT - ˜35 min 65% VO2max; n = 13)
Number of subjects: 32
Study 31125701 — intervention group
Group type: COMPARATOR
Intervention: Control (no training; n = 6)
Number of subjects: 32
Study 27814933 — intervention group
Group type: EXPERIMENTAL
Intervention: Shock wave + wrist splint
Number of subjects: 40
Study 27814933 — intervention group
Group type: COMPARATOR
Intervention: Wrist splint
Number of subjects: 40
Study 25546556 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefitinib
Number of subjects: 296
Study 25546556 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 296
Study 23764516 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose, high-repetition medical exercise therapy (MET)
Number of subjects: 28
Study 23764516 — intervention group
Group type: COMPARATOR
Intervention: Low-dose, low-repetition exercise therapy (Control)
Number of subjects: 28
Study 20613653 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight training session
Number of subjects: 30
Study 19523680 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily vaginal progesterone gel 90 mg
Number of subjects: 500
Study 19523680 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 500
Study 19523680 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone (meta-analysis)
Number of subjects: 500
Study 17095018 — intervention group
Group type: EXPERIMENTAL
Intervention: Arundic acid (AA) at 8 mg/kg/h
Number of subjects: 92
Study 17095018 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 15345913 — intervention group
Group type: EXPERIMENTAL
Intervention: Levocetirizine (LCZ)
Number of subjects: 23
Study 15345913 — intervention group
Group type: EXPERIMENTAL
Intervention: Desloratadine (DL)
Number of subjects: 23
Study 11516602 — intervention group
Group type: EXPERIMENTAL
Intervention: COMFORT 'behavior' scale
Number of subjects: 204
Study 11516602 — intervention group
Group type: COMPARATOR
Intervention: Neonates
Number of subjects: 204
Study 11516602 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain characteristics
Number of subjects: 204
Study 11516602 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical condition
Number of subjects: 204
Study 9696963 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimethicone
Number of subjects: 12
Study 9696963 — intervention group
Group type: COMPARATOR
Intervention: Control (without dimethicone)
Number of subjects: 12
Study 7654156 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐Behavioral Group Therapy (CBGT)
Number of subjects: 0
Study 7654156 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure‐based treatment without formal cognitive restructuring
Number of subjects: 0
Study 7654156 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 0
Study 2516883 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamterene (100 mg orally)
Number of subjects: 8
Study 2516883 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 1105267 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine at a daily dose of 150 mug
Number of subjects: 12
Study 1105267 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31003735 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily prolonged-release tacrolimus (PRT)
Number of subjects: 24
Study 26094993 — intervention group
Group type: EXPERIMENTAL
Intervention: Zonisamide 50 mg/d
Number of subjects: 389
Study 26094993 — intervention group
Group type: EXPERIMENTAL
Intervention: Zonisamide 25 mg/d
Number of subjects: 389
Study 26094993 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 389
Study 23165200 — intervention group
Group type: EXPERIMENTAL
Intervention: High working memory capacity (WMC) individuals
Number of subjects: 0
Study 23165200 — intervention group
Group type: EXPERIMENTAL
Intervention: Low working memory capacity (WMC) individuals
Number of subjects: 0
Study 23165200 — intervention group
Group type: EXPERIMENTAL
Intervention: Predominantly incongruent blocks
Number of subjects: 0
Study 23165200 — intervention group
Group type: EXPERIMENTAL
Intervention: Predominantly congruent blocks
Number of subjects: 0
Study 21663812 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 0.025 μg/kg/min (Group R25)
Number of subjects: 44
Study 21663812 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 0.05 μg/kg/min (Group R50)
Number of subjects: 44
Study 21663812 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 0.075 μg/kg/min (Group R75)
Number of subjects: 44
Study 18835692 — intervention group
Group type: EXPERIMENTAL
Intervention: Cobalt-chrome femoral stems
Number of subjects: 390
Study 18835692 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium femoral stems
Number of subjects: 390
Study 18835692 — intervention group
Group type: EXPERIMENTAL
Intervention: Cementless, flat, tapered wedge femoral stem design
Number of subjects: 390
Study 16398750 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepping Stones intervention (50 hours over 17 sessions in 35 communities)
Number of subjects: 2776
Study 16398750 — intervention group
Group type: COMPARATOR
Intervention: Control group (single session of about 3 hours on HIV and safer sex)
Number of subjects: 2776
Study 16398750 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepping Stones intervention
Number of subjects: 2776
Study 16398750 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2776
Study 15572499 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 0
Study 15572499 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (placebo)
Number of subjects: 0
Study 15572499 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine (preincision)
Number of subjects: 0
Study 15572499 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine (postsurgical)
Number of subjects: 0
Study 11442498 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon
Number of subjects: 4012
Study 9346997 — intervention group
Group type: EXPERIMENTAL
Intervention: Homemade CBORS
Number of subjects: 232
Study 9346997 — intervention group
Group type: EXPERIMENTAL
Intervention: Packet CBORS
Number of subjects: 232
Study 9346997 — intervention group
Group type: COMPARATOR
Intervention: Pedialyte
Number of subjects: 232
Study 9346997 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 232
Study 7658999 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine test (100 micrograms/m2 surface)
Number of subjects: 40
Study 7658999 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-Propranolol test (0.5 mg/kg weight)
Number of subjects: 40
Study 7658999 — intervention group
Group type: COMPARATOR
Intervention: Comparison of B vs B and Max Resp vs Max Resp in both groups
Number of subjects: 40
Study 3098950 — intervention group
Group type: EXPERIMENTAL
Intervention: High calcium and phosphorus content parenteral nutrition (60-80 mg Ca and 46.5-62 mg P/dl)
Number of subjects: 18
Study 3098950 — intervention group
Group type: COMPARATOR
Intervention: Low calcium and phosphorus content parenteral nutrition (20 mg Ca and 15.5 mg P/dl)
Number of subjects: 18
Study 30345850 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulatory biofeedback intervention program (HRVCB)
Number of subjects: 90
Study 30345850 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity interval training protocol (HIIT)
Number of subjects: 90
Study 30345850 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 90
Study 30345850 — intervention group
Group type: EXPERIMENTAL
Intervention: All participants (HRVCB, HIIT, and waitlist)
Number of subjects: 90
Study 27745535 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone care management (TCM)
Number of subjects: 358
Study 27745535 — intervention group
Group type: COMPARATOR
Intervention: Usual outpatient mental health treatment
Number of subjects: 358
Study 25901477 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid + pain (intravenous fentanyl 1 μg/kg and cold-pressor pain)
Number of subjects: 21
Study 25901477 — intervention group
Group type: COMPARATOR
Intervention: Opioid only (intravenous fentanyl 1 μg/kg)
Number of subjects: 21
Study 25901477 — intervention group
Group type: COMPARATOR
Intervention: Pain only (cold-pressor)
Number of subjects: 21
Study 25901477 — intervention group
Group type: COMPARATOR
Intervention: Resting condition
Number of subjects: 21
Study 24050764 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim
Number of subjects: 29
Study 24050764 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenograstim
Number of subjects: 29
Study 21527296 — intervention group
Group type: EXPERIMENTAL
Intervention: T73T mutation group
Number of subjects: 7
Study 21527296 — intervention group
Group type: COMPARATOR
Intervention: P73P mutation group
Number of subjects: 7
Study 18083065 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole for 5 years
Number of subjects: 4922
Study 18083065 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen for 5 years
Number of subjects: 4922
Study 16515924 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 157
Study 16515924 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 157
Study 14753482 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Surgical Intervention
Number of subjects: 985